Never Run Out Of Buyers To Sell To.

The ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) Network is a global network for infectious disease clinical studies. Our aim is to conduct rapid, cost-effective randomised controlled trials to deliver relevant and high quality evidence to guide clinical practice. We hope to achieve this vision through equity (shared ownership), sustainability (build long-term capacity and trust) and engagement of key stakeholders (including clinicians, scientists, governments, industry).
Annual Revenue$50M to $100M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.